Cardiovascular Systems, Inc. - Common Stock (NQ:CSII)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 27, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cardiovascular Systems, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Recent Filing Shows That Sen. Tina Smith Sold Over $100K Worth of Cardiovascular Systems Stock ↗

April 20, 2023

Via Benzinga

Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial

April 03, 2023

From Cardiovascular Systems, Inc.

Via Business Wire

CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII

March 29, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs ↗

March 14, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Why Cardiovascular Systems Stock Is Soaring Today ↗

February 09, 2023

The medtech company has agreed to a buyout offer from Abbott Laboratories.

Via The Motley Fool

Earnings Outlook For Cardiovascular Systems ↗

February 08, 2023

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)

February 22, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Which Healthcare Stock Is a Better Pick in 2023? ↗

February 14, 2023

With a potential recession on the horizon, healthcare stocks could be good picks for investors. Which of these three is best?

Via InvestorPlace

February 14, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Abbott-Cardiovascular Systems Acquisition Could Further Add Uncertainty Over Surmodics' Product: Analyst Downgrades Stock ↗

February 13, 2023

Via Benzinga

February 13, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

US Stocks Turn Lower; Dow Drops 50 Points ↗

February 09, 2023

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 50 points on Thursday. The Dow traded down 0.15% to 33,897.48 while the NASDAQ fell 0.12% to 11,896.28. The S&P 500...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 09, 2023

Via Benzinga

Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 09, 2023

Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.

Via Benzinga

MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday ↗

February 09, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Cardiovascular Systems (NASDAQ: CSII) Enters Into Agreement to be Acquired By Abbott Labs (NYSE: ABT) For $890 Million

February 09, 2023

Cardiovascular Systems, Inc. (NASDAQ: CSII) is engaged as a medical device company, which is focused on the research, development and

Via Spotlight Growth

Dow Jumps 250 Points; US Jobless Claims Increase Last Week ↗

February 09, 2023

U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose,...

Via Benzinga

Why Is Credit Suisse (CS) Stock Down 7% Today? ↗

February 09, 2023

Credit Suisse (CS) stock is falling on Thursday after announcing its intention to acquire Michael Klein's investment banking business.

Via InvestorPlace

February 09, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Why Cardiovascular Systems Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket ↗

February 09, 2023

Gainers

Via Benzinga

Why Is Vintage Wine Estates (VWE) Stock Down 28% Today ↗

February 09, 2023

Vintage Wine Estates (VWE) stock is taking a beating on Thursday after releasing an earnings update and announcing leadership changes.

Via InvestorPlace

Why Is Tivic Health Systems (TIVC) Stock Down 51% Today ↗

February 09, 2023

Tivic Health Systems (TIVC) stock is falling on Thursday with heavy trading volume after revealing pricing for a public stock offering.

Via InvestorPlace

Why Is Cardiovascular Systems (CSII) Stock Up 48% Today? ↗

February 09, 2023

Cardiovascular Systems (CSII) stock is rising higher on Thursday following news that Abbott (ABT) intends to acquire the company.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 09, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 09, 2023

We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday!

Via InvestorPlace

CSII STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Cardiovascular Systems, Inc. Is Fair to Shareholders

February 09, 2023

From Halper Sadeh LLC

Via Business Wire

Abbott Adds Complementary Technologies To Its Vascular Offering Via Cardiovascular Systems Deal For $890M ↗

February 09, 2023

Via Benzinga

Cardiovascular Systems, Inc. Reports Fiscal 2023 Second Quarter Financial Results

February 08, 2023

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023

January 19, 2023

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study

January 11, 2023

From Cardiovascular Systems, Inc.

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.